Restriction fragment analysis of individuals using cardiovascula

Details Restriction fragment analysis of individuals using cardiovascula Restriction fragment analysis of individuals using cardiovascula

1986-01-09

1989-08-29

Warden, Robert J.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

436 63, 436501, 436503, 536 27, 935 11, 935 78, 935 79, C12Q 168, G01N 3348

Patent

active

048617083

ABSTRACT:
Polymorphisms in the renin, kallikrein, and ANF gene regions are predictive for hypertension in individual human subjects.

REFERENCES:
patent: 4623619 (1986-11-01), Owerbach et al.
Rees, A., et al, "DNA Polymorphism Adjacent to Human Apoprotein A-1 Gene . . . ", The Lancet, Feb. 26, 1983, pp. 444-446.
Fojo, S. S. et al., "Analysis of the Apo C-II Gene . . . ", Biochem Biophys Res. Comm. 124(1), 308-313 (1984).
Wallis, S. C. et al, "The Isolation of a Genomic Clone . . . Apolipoprotein CII Gene . . . ", Hum Genet 68, 286-289 (1984).
Karathanasis, S. K. et al, "An inherited Polymorphism in the Apolipoprotein A-1 Gene . . .", Nature 301, 718-720 (1983).

Affiliated with

Also associated with

Rating

Restriction fragment analysis of individuals using cardiovascula does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Restriction fragment analysis of individuals using cardiovascula, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Restriction fragment analysis of individuals using cardiovascula will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2237919